Crossover study comparing bioavailability of a capsule formulation of the glucagon receptor antagonist LGD-6972 to an oral solution formulation in healthy subjects

被引：0
|
作者：
Pipkin, J. D. [1 ]
Vajda, E. [1 ]
Biernat, L. [2 ]
Klein, D. J. [2 ]
Li, Y. -X. [2 ]
Zangmeister, M. [2 ]
Zhou, R. [2 ]
Zhi, L. [1 ]
Marschke, K. [1 ]
机构：
[1] Ligand Pharmaceut Inc, San Diego, CA USA
[2] Medpace Inc, Cincinnati, OH USA
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
863
引用
收藏
页码：S399 / S400
页数：2
相关论文
共 50 条
  • [21] SINGLE DOSE BIOEQUIVALENCE BETWEEN BRIVARACETAM ORAL SOLUTION FORMULATION AND ORAL FILM-COATED TABLET IN HEALTHY SUBJECTS
    Otoul, C.
    Watanabe, S.
    Burton, I.
    Guenole, E.
    Hulhoven, R.
    McCabe, S.
    Sargentini-Maier, M.
    Stockis, A.
    EPILEPSIA, 2009, 50 : 96 - 96
  • [22] Oil-Based Curcuminoid Phospholipid Formulation Mimicking Natural Digestion Enhances Oral Bioavailability of Curcuminoids in Healthy Subjects
    Wagner, Tanja
    Wacker, Roland
    Klein, Thomas
    Kompek, Albert
    Schoen, Christiane
    JOURNAL OF MEDICINAL FOOD, 2024, 27 (05) : 396 - 403
  • [23] Relative bioavailability study of multiple receptor tyrosine kinase inhibitor ABT-869 for comparison of oral solution and tablet formulation
    Gupta, Neeraj
    Goh, Boon-Cher
    Soo, Ross
    Wong, Chiung Ing
    Zhang, Jun
    Liepold, Bernd
    Rosenber, Joerg
    Knobloch, Martin
    Steinberg, Joyce
    Humerickhouse, Rod
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3575S - 3575S
  • [24] Food effect on the oral bioavailability of Manidipine: single dose, randomized, crossover study in healthy male subjects
    D. Rosillon
    A. Stockis
    G. Poli
    D. Acerbi
    R. Lins
    B. Jeanbaptiste
    European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 : 197 - 202
  • [25] Food effect on the oral bioavailability of Manidipine: single dose, randomized, crossover study in healthy male subjects
    Rosillon, D
    Stockis, A
    Poli, G
    Acerbi, D
    Lins, R
    Jeanbaptiste, B
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (02) : 197 - 202
  • [26] Crossover Study Comparing Bioavailability of Captisol-Enabled Iohexol Injection to Reference Iohexol Injection in Healthy Subjects
    Marschke, K.
    Larouche, R.
    Boudreault, S.
    Lapointe, C.
    Antle, V.
    Vajda, E.
    Zhi, L.
    Pipkin, J.
    INVESTIGATIVE RADIOLOGY, 2019, 54 (12) : 792 - 793
  • [27] Relative Bioavailability of Diclofenac Potassium From Softgel Capsule Versus Powder for Oral Solution and Immediate-Release Tablet Formulation
    Bende, Girish
    Biswal, Shibadas
    Bhad, Prafulla
    Chen, Yuming
    Salunke, Atish
    Winter, Serge
    Wagner, Robert
    Sunkara, Gangadhar
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2016, 5 (01): : 76 - 82
  • [28] Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design
    Séchaud, R
    Graf, P
    Bigler, H
    Gruendl, E
    Letzkus, M
    Merz, M
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2002, 40 (01) : 35 - 40
  • [29] Evaluation of the absolute oral bioavailability and bioequivalence of erlotinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in a randomized, crossover study in healthy subjects
    Frohna, P
    Lu, JF
    Eppler, S
    Hamilton, M
    Wolf, J
    Rakhit, A
    Ling, J
    Kenkare-Mitra, SR
    Lum, BL
    JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (03): : 282 - 290
  • [30] Preclinical and Clinical Pharmacokinetics and Bioavailability in Healthy Volunteers of a Novel Formulation of the Selective P2X3 Receptor Antagonist Eliapixant
    Francke, Klaus
    Chattopadhyay, Niladri
    Klein, Stefan
    Rottmann, Antje
    Krickau, Dennis
    van de Wetering, Jeroen
    Friedrich, Christian
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (01) : 75 - 87
12345